Keith Bruhnsen is a Visante Sr. Consultant who is an expert in employee prescription drug benefits plan administration.
Keith’s career began as a counselor in public mental health organizations and in private practice. He eventually transitioned into employment at the University of Michigan at Ann Arbor where he is now Assistant Director of the Benefits Administration Office and Manager of the University’s prescription drug plan. In addition, he oversees contract development, vendor relations, coordinates with internal P&T and Campus Rx Oversight Committees, as well as facilitates various academic research projects regarding the program’s utilization management and overall plan design. He is the lead benefit representative during collective bargaining with the University’s eight unions and has represented U-M in a number of local and state healthcare coalitions.
Under Keith’s leadership, the U-M employee prescription drug program has received national awards and much media attention for its innovation and significant cost savings. The compassion and understanding that guided his counseling practice still motivates his dedication to providing a quality drug plan. He insists on using evidence-based decision making and selecting only the best-in-class vendors and best-value medications without sacrificing the benefit plan’s fiduciary responsibility to the University and to its plan members.
Before taking on responsibility for prescription drug plan Keith provided administrative oversight and development for a dozen years in the U-M Human Resources Employee Assistance Program. Using his experience as a mental health counselor, he administered the first US professional brief intervention and secondary prevention educational program for problem drinkers. This program required coordination with healthcare and other provider/referral services in the state.
Keith Bruhnsen has a Master of Social Work Degree (MSW) from the University of Michigan and Bachelor of Science degree in psychology from the Eastern Michigan University. He speaks at numerous conferences and has presented at workshops for pharmacy benefit managers. Recently, he was asked to provide testimony for the ERISA Advisory Council on PBM Compensation and Fees.